Patent Thickets Constrain US Biosimilars Market

Patent Thickets Constrain US Biosimilars Market

Biosimilars represent a significant cost-savings opportunity in the United States because they can introduce competition for some of the most expensive and widely used prescription drugs on the market: originator biologics. Several market and regulatory barriers have slowed biosimilar market entry and uptake in the United States.